We harness AI to accelerate drug discovery
We use artificial intelligence (AI) technology to explain the physical and chemical nature of biological systems.
What is our philosophy?
Drug Discovery Pipeline
AI Approach and Solutions
Learn More
Evommune and Accutar Biotechnology Announce AI Drug Discovery Collaboration
Nov 28, 2023
Read More
Dr. Erika Hamilton Joined Scientific Advisory Board of Accutar Biotech
Sep 11, 2023
Read More
Accutar Biotechnology Announces First Patient Dosed with AC0676 in Phase 1 Study in Patients with Relapsed/Refractory B-cell Malignancies
Jun 20, 2023
Read More